newsfilter
← Latest News
Business Wire·

Axcella to Present at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting

Axcella Therapeutics (NASDAQ:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, today announced that